<DOC>
	<DOCNO>NCT01675206</DOCNO>
	<brief_summary>This study aim find optimal dose Vitamin K2 supplementation hemodialysis patient .</brief_summary>
	<brief_title>Dose Defining Study Administration Vitamin K2 Supplements Hemodialysis Patients</brief_title>
	<detailed_description>During past year evidence emerge role Matrix Gla Protein ( MGP ) one powerful inhibitor vascular calcification ( Shurgers LJ et al . Thromb Haemost 2008 ; 100 : 593-603 ) . MGP Vitamin K dependent protein . This mean presence Vitamin K2 require promote gamma-carboxylation process turn MGP carboxylate active form . Recent data show dp-uc MGP correlate well Vitamin K status ( Cranenburg CM et al . Thrombosis Haemostasis 2010 ; 104/4 : 811-822 ) . It widely recognize patient renal insufficiency treat hemodialysis prone accelerate vascular calcification result excess cardiovascular morbidity mortality ( Goodman WG et al . N Engl J Med 2000 ; 342 : 1478-1483 ) . Consequently , administration Vitamin K2 supplement may protect hemodialysis patient accelerate vascular calcification enhance gamma-carboxylation process MGP . However , optimal dose Vitamin K2 require achieve result remains define</detailed_description>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>age â‰¥18 year sign informed consent end stage renal disease treat chronic hemodialysis least three time week coumarin treatment know intestinal malabsorption inability take oral medication medical condition considerable probability death within 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Vascular calcification</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Matrix Gla Protein</keyword>
	<keyword>Vitamin K2</keyword>
</DOC>